Sava Infond d.o.o. acquired a new stake in shares of Enovix Co. (NASDAQ:ENVX – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 4,000 shares of the company’s stock, valued at approximately $43,000.
A number of other institutional investors have also recently made changes to their positions in ENVX. Old West Investment Management LLC boosted its stake in Enovix by 12.3% during the third quarter. Old West Investment Management LLC now owns 937,838 shares of the company’s stock valued at $8,759,000 after buying an additional 102,452 shares during the last quarter. Natixis Advisors LLC boosted its position in shares of Enovix by 93.9% during the 3rd quarter. Natixis Advisors LLC now owns 31,028 shares of the company’s stock valued at $290,000 after acquiring an additional 15,030 shares during the last quarter. Quest Partners LLC grew its holdings in shares of Enovix by 318.5% in the third quarter. Quest Partners LLC now owns 8,270 shares of the company’s stock valued at $77,000 after purchasing an additional 6,294 shares in the last quarter. Intech Investment Management LLC bought a new position in Enovix during the third quarter valued at $394,000. Finally, Charles Schwab Investment Management Inc. grew its stake in shares of Enovix by 6.3% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,229,052 shares of the company’s stock worth $11,479,000 after buying an additional 73,320 shares in the last quarter. Hedge funds and other institutional investors own 50.92% of the company’s stock.
Enovix Trading Down 1.6 %
Shares of NASDAQ ENVX opened at $8.01 on Friday. The business’s 50 day moving average price is $9.98 and its 200-day moving average price is $10.03. Enovix Co. has a fifty-two week low of $5.70 and a fifty-two week high of $18.68. The company has a debt-to-equity ratio of 0.99, a quick ratio of 3.61 and a current ratio of 3.77. The company has a market cap of $1.53 billion, a price-to-earnings ratio of -5.52 and a beta of 1.93.
Analyst Upgrades and Downgrades
ENVX has been the subject of a number of analyst reports. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $30.00 price target on shares of Enovix in a report on Thursday, February 20th. Craig Hallum lowered their price objective on Enovix from $20.00 to $18.00 and set a “buy” rating for the company in a research note on Thursday, February 20th. Two research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, Enovix presently has an average rating of “Moderate Buy” and an average target price of $20.30.
View Our Latest Research Report on ENVX
Insider Buying and Selling at Enovix
In other Enovix news, CEO Rajendra K. Talluri sold 300,000 shares of Enovix stock in a transaction on Thursday, February 27th. The stock was sold at an average price of $9.35, for a total transaction of $2,805,000.00. Following the completion of the sale, the chief executive officer now directly owns 2,045,301 shares of the company’s stock, valued at $19,123,564.35. The trade was a 12.79 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 15.70% of the stock is owned by corporate insiders.
Enovix Profile
Enovix Corporation designs develops and manufactures silicon-anode lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.
Featured Articles
- Five stocks we like better than Enovix
- How to buy stock: A step-by-step guide for beginners
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to Sell
- 5 Top Rated Dividend Stocks to Consider
- Top 3 Beverage Stocks Pouring Out Profits
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- CarMax and Carvana: Steering the Used Car Market
Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.